Colorado Springs Neurological Associates is one of the largest and longest-standing neuroscience medical practices in southern Colorado. 

Our aim is to deliver the highest standard of neurological care – the same level of care we would want for ourselves or our loved ones.  The Center has a dedicated clinical research institute with experienced principal investigators and full-time research staff. 

Collectively, our investigators have vast experience conducting phase II through phase IV clinical trials in a broad range of neurologic diseases affecting adults and children.


Adult Migraine

  • Phase 4 study evaluating outcomes for migraine patients in real world healthcare systems 
  • Oral ubrogepant in the treatment of migraine when administered during migraine prodromal phase 

Pediatric Migraine

  • Erenumab (Aimovig) for episodic and chronic migraine prophylaxis, 6-18 years of age
  • A multicenter, randomized, double blind, placebo controlled, parallel-group study comparing the efficacy, safety and tolerability of subcutaneous administration of fremanezumab versus placebo for the prophylactic treatment of chronic or episodic migraine in pediatric patients, 6-17 years of age
  • A randomized, double-blind, placebo-controlled study of lasmiditan for acute treatment of migraine 

Multiple Sclerosis

  • Phase 4 observational trial for Multiple Sclerosis patients taking cladribine 
  • Phase 4 observational trial for Multiple Sclerosis patients taking siponimod 
  • Phase 3, randomized, double-blind efficacy and safety study comparing SAR442168 to teriflunomide (Aubagio®) in participants with relapsing forms of multiple sclerosis 
  • Phase 3, randomized, double-blind, efficacy and safety study comparing SAR442168 to placebo in participants with non-relapsing secondary progressive multiple sclerosis 
  • Phase 4 study evaluating the processing speed of MS patients treated with ozanimod  

Neurogenic Orthostatic Hypotension

  • Phase 4 long-term outcome study of droxidopa (Northera) in patients with orthostatic hypotension
  • Phase 3 trial to assess the safety and efficacy of TD-9855 in neurogenic orthostatic hypotension

 Trigeminal Neuralgia

  • Phase 3 study evaluating the efficacy and safety of vixotrigine in subjects with trigeminal neuralgia

 Myasthenia Gravis

  • Phase 3 trial to assess the safety and efficacy of ravulizumab in patients with Myasthenia Gravis
  • Phase 2a, multi-center, randomized, double-blind, placebo- controlled study with an open-label extension of RVT-1401 in Myasthenia Gravis

Please contact the research coordinator, Jodi for additional information:

Jodi Ventimiglia 719-389-1126  jventimiglia@csneuro.com

Jennifer Orban jorban@csneuro.com

Contact Us
Call (719)473-3272 to Make an Appointment Today!

Complete the form below and a representative will contact you shortly.

  • This field is for validation purposes and should be left unchanged.
Sign Up for Our FREE Newsletter!

Be the first to learn about exciting new treatment options and important news from CSNA.

  • This field is for validation purposes and should be left unchanged.
*By clicking the submit button, you agree to receive periodic emails from Colorado Neurological Associates (CSNA) about important information and health-related news. You can easily unsubscribe at any time.

Colorado Springs Neurological Associates (CSNA) recognizes that neurological disease doesn’t stop for a pandemic. While under the restrictions of COVID-19, telehealth appointments will be made available to our patients.

In person appointments are still available; however, if you’re sick, immunocompromised, or would just prefer a telehealth appointment, please call our scheduling department at 719-473-3272.

X